-
ASCO in Five Minutes | Professor Chuanliang Cui: Advances in First-Line Treatment of Advanced Melanoma
With the continuous emergence of novel therapeutic agents, treatment strategies for advanced melanoma have evolved from traditional chemotherapy and radiotherapy to include immunotherapy, targeted therapy, chemotherapy, and their combinations. Global researchers are constantly exploring and optimizing treatment options for first-line therapy in advanced melanoma. At the 2024 American Society of Clinical Oncology (ASCO 2024) Annual…
-
Planning and Action: Leading Oncology Experts Discuss the Development and Future Prospects of ADCs in China
In recent years, with the advancement of innovative mechanisms and technologies, antibody-drug conjugates (ADCs) have become a research hotspot. ADC drugs have further promoted clinical development, clinical translation, and patient treatment outcomes. Recently, the high-level closed-door seminar “Planning and Action, Breaking Through the Billion-Dollar ADC Market,” hosted by the Oriental Clinical Oncology Research Center, China…
-
From Later Lines to Front Lines, New ADCs Bring Survival Benefits to More Patients with HER2 Overexpression and HER2 Ultra-Low Expression
The mid-year meeting of the Youth Expert Committee of the Chinese Society of Clinical Oncology (CSCO YOUNG) was held from June 28-30, 2024, in Shanghai, where young elites from across the country gathered to discuss academic progress. Recent updates and announcements from various DESTINY-Breast (DB) series studies have brought more benefits to patients with HER2-positive,…
-
Professor Simon J. Crabb: Evaluating Self-Help CBT for Hot Flushes and Night Sweats in Prostate Cancer Patients on ADT in the MANCAN2 Study
ASCO International Perspective | experience hot flushes and night sweats (HFNS), which not only decrease their quality of life but may also affect compliance with ADT. Current relief methods are limited. At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Professor Simon J. Crabb from the University Hospital Southampton presented the results of…
-
BOC/BOA 2024 | Professor Tian Yang: Annual Advances in Chinese Clinical Oncology 2023 (Hepatobiliary and Pancreatic Tumors)
Since 2015, the Chinese Society of Clinical Oncology (CSCO) has adhered to the philosophy of “International Standards, Chinese Characteristics, Learning and Absorbing, Innovating and Improving,” launching the “Annual Research Advances in Chinese Clinical Oncology” for nine consecutive years. At the recently held “2024 Annual Progress Seminar on Chinese Clinical Oncology (BOC) and Best of ASCO…
-
Professor Qing Xie: Contributions and Challenges of Long-Acting Interferon in the Clinical Cure of Chronic Hepatitis B
Antiviral treatment can maximize the long-term suppression of hepatitis B virus (HBV) DNA replication, reducing liver necrosis, fibrosis, cirrhosis, liver cancer, and other complications, thereby improving the quality of life and extending the survival time of hepatitis B patients. Currently, long-acting interferon is recommended as a first-line treatment option by guidelines in Europe, the United…
-
APACC2024 | Dr. Chunyan Li: Service Provision and Adherence Support for HIV Pre-Exposure Prophylaxis (PrEP)
Numerous studies have explored the use of long-acting antiretroviral therapy (Long-acting ART) for HIV pre-exposure prophylaxis (PrEP), achieving positive preventive outcomes. However, the promotion of long-acting PrEP still faces many challenges. Additionally, how can adherence to existing oral PrEP regimens be further improved? At the recently held 9th Asia Pacific AIDS & Co-infections Conference (APACC…
-
Exempting RNI in Post-BCS pN1 Breast Cancer Patients Who Have Undergone Taxane-Based Chemotherapy
For most patients, postoperative radiotherapy plays a crucial role. Some early-stage breast cancer patients require prophylactic regional lymph node irradiation (RNI) in addition to whole-breast irradiation (WBI). However, the survival benefit of RNI for patients with 1-3 positive axillary lymph nodes (pN1) remains uncertain. Therefore, it’s necessary to evaluate the impact of RNI on the…
Connecting Medical Expertise through Media